Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study.
Raoul C ReulenKwok F WongChloe J BrightDavid L WinterDaniela AlessiRodrigue Setcheou AllodjiFrancesca BagnascoEdit BárdiAndrea BautzJulianne ByrneElizabeth Am FeijenMiranda M Fidler-BenaoudiaIbrahim DialloStanislaw GarwiczDesiree GrabowThorgerdur GudmundsdottirJoyeeta GuhaNadia HaddyStine HøgsholtMoncilo JankovicPeter KaatschMelanie KaiserRahel KuonenHelena LingeHilde ØfstaasCecile M RonckersEva-Maria HauRoderick SkinnerFlora E van LeeuwenJop C TeepenCristina VeresWael ZrafiGhazi DebicheDamien LlanasMonica TerenzianiGiao Vu-BezinFinn WesenbergThomas WiebeCarlotta SacerdoteZsuzsanna JakabRiccardo HauptPäivi M LähteenmäkiLorna Zadravec ZaletelClaudia E KuehniJeanette F WintherFlorent de VathaireLeontien C KremerLars HjorthMichael M HawkinsPublished in: Gut (2020)
Colonoscopy surveillance before age 55 is recommended in many European countries for individuals with a family history of colorectal cancer, but not for WT and HL survivors despite a comparable risk profile. Clinically, serious consideration should be given to the implementation of colonoscopy surveillance while further evaluation of its benefits, harms and cost-effectiveness in WT and HL survivors is undertaken.